Tolerogenic and immunogenic states of Langerhans cells are orchestrated by epidermal signals acting on a core maturation gene module.
Marta E PolakHarinder SinghPublished in: BioEssays : news and reviews in molecular, cellular and developmental biology (2021)
Langerhans cells (LCs), residing in the epidermis, are able to induce potent immunogenic responses and also to mediate immune tolerance. We propose that tolerogenic and immunogenic responses of LCs are directed by signaling from the epidermis and involve counter-acting gene circuits that are coupled to a core maturation gene module. We base our analysis on recent genetic and genomic findings facilitating the understanding of the molecular mechanisms controlling these divergent immune functions. Comparing gene regulatory network (GRN) analyses of various types of dendritic cells (DCs) including LCs we integrate signaling-dependent (TGFβ, EpCAM, β-Catenin) and transcription factor (IRF4, IRF1, NFκB) regulated gene circuits that appear to orchestrate the distinctive LC functional states. Our model proposes, that while epidermal signaling in the steady-state promotes LC tolerogenic function, the disruption of cell-cell contacts coupled with inflammatory signaling induces LC immunogenic programing. The conceptual framework emphasizes the sensing of discrete epidermal and inflammatory cues by resident LCs in dictating their genomic programing and cell state dynamics.
Keyphrases
- dendritic cells
- copy number
- genome wide
- transcription factor
- regulatory t cells
- single cell
- immune response
- induced apoptosis
- genome wide identification
- oxidative stress
- cell therapy
- signaling pathway
- cell proliferation
- stem cells
- dna methylation
- wound healing
- cell death
- tandem mass spectrometry
- mesenchymal stem cells
- bone marrow
- liquid chromatography
- high resolution
- lps induced
- inflammatory response
- patient safety
- dna binding
- circulating tumor cells